Upon penetration into cancerous spheroids, these nanoparticles downregulate HIF-1α expression and reduce hypoxia, offering an alternative strategy to regulate cytotoxic immune cells in the tumor microenvironment and improve adoptive NK cell therapy. The gene discussed is HIF1A; the disease is neoplasm.